Skip to main content
. 2014 Jul 3;4:5550. doi: 10.1038/srep05550

Figure 3. Viability of HF cells upon gB-GNPsp, gB-GNPst or gB-GNPop treatment.

Figure 3

Nanoparticles (conjugated to 100 ng anti gB antibody total) were added to HF at the time of infection (I) with CMV (AD169) at an MOI of 3.0 or the cells were mock-infected (UI) and/or mock-treated (UT). Cell viability was recorded at 8 hpi (A) or at 5 dpi (B) using trypan blue exclusion assay.

HHS Vulnerability Disclosure